Tetrabenazine Tablet
Product Images NDC 69452-117

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tetrabenazine (NDC 69452-117). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bionpharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1 (Spl Tetrabenazine Figure 001)

Figure 1 (Spl Tetrabenazine Figure 001)
This is a description of a study that evaluated the changes in chorea score in 84 HD patients treated with either Tetrabenazine or Placebo. The data shows that patients treated with Tetrabenazine experienced a significant reduction in their chorea score compared to those receiving Placebo.*
FDA Label Image

Figure 2 (Spl Tetrabenazine Figure 002)

Figure 2 (Spl Tetrabenazine Figure 002)
The text is describing a study result for two treatment groups, Tetrabenazine and Placebo. It includes a table showing the cumulative percentage of patients, change in total Chorea score and the percentage of randomized patients who completed the study. It also includes a graph that shows the cumulative percentage of patients with specified changes from baseline in total Chorea score.*
FDA Label Image

Structural Formula (Spl Tetrabenazine Structure Formula)

Structural Formula (Spl Tetrabenazine Structure Formula)
FDA Label Image

12.5 mg Container Label (Tetraimage001v1)

12.5 mg Container Label (Tetraimage001v1)
This seems to be a label or a prescription guide for medication named "Tetrabenazin" which contains 12.5 mg tablets and is distributed by Ionpharma Inc. The text includes some identification codes (NDC 69452-117-21 and M.L. 164/MN/AP/9S/F/R 1217) and contact information for both the distributor and the manufacturer, Natco Pharma Limited, located in Telangana, INDIA. The text also mentions the recommended use of the medication by patients, but it is not clear what the condition it is targeting.*
FDA Label Image

25 mg Container Label (Tetraimage002v1)

25 mg Container Label (Tetraimage002v1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.